Navigation Links
Mystery dissolves with calcium pump discovery
Date:11/30/2010

Geo-microbiologists from Arizona State University have solved a long-standing conundrum about how some photosynthetic microorganisms, endolithic cyanobacteria, bore their way into limestone, sand grains, mussel shells, coral skeletons and other substrates composed of carbonate.

According to the lead investigator, ASU professor Ferran Garcia-Pichel, the answer to the mystery of what is "at the heart of an erosive force of global proportions" is a calcium-driven pump, similar to that which we use to power our muscles.

The results of Garcia-Pichel's study "Microbial excavation of solid carbonates powered by P-type ATPase-mediate transcellular Ca 2+ transport" were published Nov. 29 in the Proceedings of the National Academy of Sciences (PNAS).

While the dissolution of the carbonate coral reefs was noted more than a century ago by Louis Agassiz, the father of American naturalists, the specifics of how this physiological process occurs has remained a mystery. In fact, the process has presented a geochemical paradox to scientists, in that most cyanobacteria tend to precipitate new carbonates, not dissolve them.

Typically cyanobacteria, by photosynthesizing, raise the pH of the water (and lower the acidity); this process typically causes carbonate to precipitate if the change is large enough. While that is the "normal" case, the paradox with boring cyanobacteria is that photosynthesis occurs at the same time that they dissolve carbonate structures (which typically requires the pH to go down, making the environment more, rather than less acidic).

Garcia-Pichel and coauthors, Edgardo Ramrez-Reinat, a doctoral candidate, and Qunjie Gao, a faculty research associate, in the School of Life Sciences in ASU's College of Liberal Arts and Sciences, set about trying to understand how this select group of carbonate-boring species can excavate by coaxing a strain of Mastigocoleus testarum, a filamentous, branching cya
'/>"/>

Contact: Margaret Coulombe
Margaret.Coulombe@asu.edu
480-727-8934
Arizona State University
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. VIMS scientists help solve mystery of alien pod
2. A mystery solved: How genes are selectively silenced
3. Scientists solve mystery of arsenic compound
4. Marine scientists unveil the mystery of life on undersea mountains
5. Toward resolving Darwins abominable mystery
6. Interdisciplinary research looks at Charlottes green mystery
7. Mystery unraveled: How asbestos causes cancer
8. Answer to saliva mystery has practical impact
9. Solution to beading-saliva mystery has practical purposes
10. Uncovering the mystery of a major threat to wheat
11. A Dicty mystery solved
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Mystery dissolves with calcium pump discovery
(Date:8/20/2015)... Aug. 20, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market and ... joined The Smart Card Alliance and the EMV Migration ... and the Smart Card Alliance Latin America (SCALA) Chapter ... peers and thought leaders promoting adoption of smart card ...
(Date:8/12/2015)... MINNETONKA, Minn. , Aug. 12, 2015   ... that supports the entire spectrum of clinical research, is ... ™ , the company,s comprehensive SaaS-based eClinical technology platform, ... growth during the first two quarters of 2015.   ... and second largest quarters measured by contract value sold ...
(Date:8/10/2015)... TELTOW, Germany , August 10, 2015 ... a world leader in Eye Tracking Technology for more ... OEM Eye Tracking Platform for integration into all consumer ... reference designs for seamless integration of eye tracking into ... HMDs and augmented reality smart glasses. Omnivision,s leading sensor ...
Breaking Biology News(10 mins):NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 2NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 4MedNet Solutions Experiences Explosive Corporate Growth 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3
... Studies show the incidence of diabetes in dogs has increased ... Missouri veterinarians have changed the way veterinarians treat diabetes in ... humans. Dogs are susceptible to type 1, insulin-dependent diabetes. ... because their bodies do not produce enough insulin, a hormone ...
... around the world have forced many species to the brink ... multiple causes that are still not fully understood, researchers conclude ... causative factor is often missing the larger picture, they said, ... don,t consider the totality of causes or could even ...
... April 25, 2011 - Call them the Jason Bournes of ... secret agents, some bacteria avoid antibiotic treatments by essentially shutting ... says Thomas Wood, professor in the Artie McFerrin Department of ... elaborate survival mechanism is explained in the online April edition ...
Cached Biology News:MU researchers pioneer animal diabetes treatment 2Catastrophic amphibian declines have multiple causes, no simple solution 2Catastrophic amphibian declines have multiple causes, no simple solution 3'Going off the grid' helps some bacteria hide from antibiotics 2'Going off the grid' helps some bacteria hide from antibiotics 3
(Date:8/31/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/k6lcp2/mexico_biomedical ) has announced ... - Growth, Trends & Forecasts (2014-2020)" report to ... Sensors market is estimated at $0.20 billion by 2018 ... The near future will bring biomedical sensors ... individual. These sensors can be set to trigger alerts ...
(Date:8/31/2015)... TORONTO , Aug. 31, 2015 /PRNewswire/ - Portage ... Canadian Securities Exchange: PBT.U), is pleased to announce that ... be advancing its lead candidate, PPL-003, to an Investigational ... dry eye disease and uveitis.  PPL recently completed a ... where topical PPL-003 solution achieved highly significant efficacy and ...
(Date:8/31/2015)... Aug. 31, 2015 FLX Bio, Inc., a ... novel cancer immunotherapies, announced today that it has appointed ... Officer and William Ho , M.D., Ph.D., as ... experienced management team led by veterans of Flexus Biosciences, ... Chief Scientific Officer; Jay Powers , Ph.D., Vice ...
(Date:8/31/2015)... ... August 31, 2015 , ... The Food Processing Suppliers Association's ... processors, equipment manufacturers and leaders in the field of academia. , METTLER ... for manufacturers of bakery and snacks; beverages; dairy; meat, poultry and seafood; and ...
Breaking Biology Technology:Mexico Biomedical Sensors Market Report 2015-2020 2Portage's PPL will advance its lead candidate PPL-003 to an IND for dry eye disease and uveitis 2Portage's PPL will advance its lead candidate PPL-003 to an IND for dry eye disease and uveitis 3FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 2FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 3FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 4METTLER TOLEDO Hosts Food Safety Educational Center at 2015 PROCESS EXPO 2
... ... new partner and sponsor in Life Line Screening. The two companies aim to ... abdominal aortic aneurysm and , peripheral arterial disease screening . Life Line ... its customers can easily donate money to the foundation. , ...
... , SAN DIEGO, Dec. 9 ... top-line efficacy and safety results from the Tulip PETAL Study ... proprietary, orally-active nonpeptide Gonadotropin-Releasing Hormone (GnRH) receptor antagonist, elagolix, in ... data from the Tulip PETAL Study are consistent with what ...
... , Nashville, Tenn., Dec. 9 Cumberland Pharmaceuticals ... entered into an exclusive agreement with DB Pharm Korea Co. ... ( ibuprofen ) Injection in South Korea. Designed to treat pain ... U.S. Food and Drug Administration and launched by Cumberland in the ...
Cached Biology Technology:Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4